Business · 04/02/2022Updated: 10/17/2026 · 1 min read
FDA Withdraws Proposed Rule on Prescription Drug Marketing Act, Citing Duplication with Other Rulemaking
Summary
The Food and Drug Administration (FDA) has withdrawn its proposed rule on removing certain requirements related to the Prescription Drug Marketing Act, citing duplication with another proposed rule intended to conform with the Drug Supply Chain Security Act of 2013, which was published in the Federal Register on July 14, 2011.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →